Manufacturer
PHARMANIAGA MANUFACTURING BERHAD
Contents
Clobetasol propionate
Indication
Short-term treatment of inflammatory &/or pruritis associated w/ acute & chronic corticosteroid-responsive dermatoses.
Instruction
Adult & childn >12 yr Apply thin film to affected area bd-tds. Max: 50 g wkly. Max duration: 2 consecutive wk.
Drug interaction
Increased systemic exposure w/ CYP3A4 enzyme inhibitors (e.g. itraconazole, ritonavir). May diminish the antineoplstic effect of aldesleukin. May potentiate the hyperglycaemic effect of ceritinib. May diminish the therapeutic effect of corticorelin and hyaluronidase. May enhance the adverse/toxic effects of deferasinox.
Malaysia
